1. Am J Med. 2020 Jul;133(7):781-782. doi: 10.1016/j.amjmed.2020.01.016. Epub
2020  Feb 12.

Does Metformin Interfere With the Cardiovascular Benefits of SGLT2 Inhibitors? 
Questions About Its Role as the Cornerstone of Diabetes Treatment.

Packer M(1).

Author information:
(1)Baylor Heart and Vascular Institute, Baylor University Medical Center, 
Dallas, Tex; Imperial College, London, UK. Electronic address: 
milton.packer@baylorhealth.edu.

DOI: 10.1016/j.amjmed.2020.01.016
PMID: 32061625 [Indexed for MEDLINE]
